Fucoxanthin ameliorated scopolamine-induced [135] and Aβ oligomer-induced [117] cognitive impairments in mice, possibly by inhibiting AChE activity and OS, modulating ChAT activity, and increasing BDNF expression. This evidence concerns the gene BDNF and Cognitive impairment.